Form 4: Integra LifeSciences Director Jeffrey Graves Reports Transaction
SEC Form 4 Filing
Director Jeffrey Graves reports acquisition and disposal of common stock in Integra LifeSciences Holdings Corp.
Summary
- On May 9, 2025, Director Jeffrey A. Graves reported a transaction involving Integra LifeSciences Holdings Corp. common stock.
- Graves acquired 19,592 shares of common stock.
- Graves disposed of 32,086 shares of common stock.
- Following the transaction, Graves beneficially owns 32,086 shares of Integra LifeSciences Holdings Corp.
- A Power of Attorney was executed on May 9, 2025, granting Lesha Shinn, Chantal Veillon, and John Siemann the authority to act on behalf of Jeffrey Graves in matters related to SEC filings.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a director's transaction, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider trading activities, which are common and regulated to ensure transparency and prevent illegal activities.
Stakeholder Impact
- Shareholders are informed about the transactions of a company director, contributing to transparency.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of earliest transaction (acquisition and disposal of shares) and execution of Power of Attorney. |
| 05/13/2025 | Date of signature by Attorney-in-Fact on the report. |
Keywords
Form 4, Integra LifeSciences, IART, Jeffrey Graves, Director, Beneficial Ownership, SEC Filing, Power of Attorney, Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.